ALLOMEK THERAPEUTICS
Allomek Therapeutics is a privately held pharmaceutical company committed to helping cancer patients by the discovery and development of targeted therapies. Allomek’s primary interest lies in the inhibition of targets associated with the Ras pathway. Allomek has discovered a novel class of MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. Allomek’s clinical candidate, CIP-1374, is an allosteric MEK kinase inhibitor that combines potent activity against MEK1/2 kinase and against chemo-resistant ovarian cancer stem cells.
ALLOMEK THERAPEUTICS
Industry:
Biotechnology Clinical Trials Pharmaceutical Therapeutics
Address:
Farmington, Connecticut, United States
Country:
United States
Website Url:
http://www.allomek.optimatrix.net
Status:
Closed
Contact:
203-208-2811
Email Addresses:
[email protected]
Total Funding:
150 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Domain Not Resolving AJAX Libraries API Foundation
Current Employees Featured
Founder
Investors List
Connecticut Innovations
Connecticut Innovations investment in Pre Seed Round - AlloMek Therapeutics
Official Site Inspections
http://www.allomek.optimatrix.net
Unable to get host informations!!!
